Social determinants of health (SDOH) encompass a range of social, environmental, and economic factors that can influence health status and have a major impact on people’s quality of life. The Population Health Leaders Network (PHLN) has renewed their commitment to addressing SDOH and is actively seeking partners across all healthcare sectors who are interested in… Continue reading PHLN Social Determinants of Health Infographic
Tag: NOEs
The Population Health Leaders Network Invites Healthcare Stakeholders to Collaborate on Addressing Social Determinants of Health
NEW YORK, April 1, 2022 – Due to the increased urgency with efforts to address Social Determinants of Health (SDOH), the Population Health Leaders Network (PHLN) announced it is actively seeking partners across all healthcare sectors who are interested in collaborating on this area of need.
Women’s Health research Collaborative Launches Multi-stakeholder Initiatives Around Unmet Women’s Health Needs
NEW YORK, March 8, 2021 – The Women’s Health research Collaborative (WHrC) announces the launch of a multi-stakeholder initiative designed to raise awareness and address the burden of women’s health issues through patient-centered research. Key stakeholders include health systems, advocacy groups, life science organizations, payers, employers, and consumer facing technology organizations who are contributing their influence to activate change within the health care system and society.
The Kinetix Group (TKG) Launches The Population Health Leaders Network™ To Help Navigate Changing Care Delivery
NEW YORK, October 20, 2020 – 2020 has seen a dramatic shift in healthcare needs, the impact of which is expected to continue well into the future. To accelerate healthcare innovations to support these needs, The Kinetix Group is excited to launch The Population Health Leaders Network™ (PHL Network). This network aims to collect and share cutting-edge insights and real-world evidence on emerging best practices for care delivery models. The charter group is comprised of leaders from prominent health systems, representing over 11 million patients.
PM360 Announces NASHNET, pioneered by The Kinetix Group, as a Finalist for Its 2019 Trailblazer Award
NEW YORK, August 27, 2019 – NASHNET has been selected as a finalist in the 11th annual PM360 Trailblazer Awards within the Product/Service Launch category. NASHNET is a unique, care delivery model for the treatment of non-alcoholic fatty liver disease (NAFLD) that was founded and launched in 2018 by The Kinetix Group (TKG). TKG has been chosen alongside reputable marketing firms and industry powerhouses for this award.
The Kinetix Group has Been Recognized by Medical Marketing & Media as a Top 100 Healthcare Agency
NEW YORK, July 18, 2019 – The Kinetix Group (TKG), a New York City-based life sciences marketing agency and care delivery consultancy, has been recognized by Medical Marketing & Media (MM&M) as a top 100 healthcare agency.
Univision Joins NASHNET in Advancing Awareness of NASH in Latino Populations
NEW YORK, June 11, 2019 – NASH Network (NASHNET), a global Centers of Excellence Network represented by leading healthcare systems in collaboration with The Kinetix Group, is committed to non-alcoholic steatohepatitis (NASH) care delivery innovation with a mission to create a standard of care for NASH, a high-volume chronic condition.
NASHNET Expands Into the European Union
NEW YORK, May 16, 2019 – NASHNET, powered by The Kinetix Group, has focused its efforts on expanding its reach to the European Union. NAFLD/NASH is an international issue, affecting nearly 1 billion people around the world.1
The Kinetix Group Partners with Rimidi to Launch a Clinical Care Partnership for the Management of Nonalcoholic Steatohepatitis (NASH)
NEW YORK, August 30, 2018 – The Kinetix Group in partnership with Rimidi, an Atlanta-based health care technology firm, announced a partnership focused on improving Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) care delivery leveraging NASHNET, a global centers of excellence network.
The Nonalcoholic Steatohepatitis (NASH) Network in Collaboration with Echosens Launches a Real World Evidence Model
NEW YORK, August 23, 2018 – The global NASH market is projected to reach $21.5 billion by 2025, with NASH being the leading cause of liver transplantation in the US in the coming years. 1 The NASH Network (NASHNET), in collaboration with The Kinetix Group, has launched a Real World Evidence study to optimize care delivery for patients with Non-Alcoholic Steatohepatitis (NASH). This initiative is in partnership with Echosens, the innovators and marketers of the FibroScan® family of products.